These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22647522)

  • 1. Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology.
    Xiu MH; Chen DC; Wang D; Zhang K; Dong A; Tang W; Zhang F; Liu LJ; Liu JH; Liu HB; Yang FD; Kosten TR; Zhang XY
    J Psychiatr Res; 2012 Aug; 46(8):1093-8. PubMed ID: 22647522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia.
    Fu YY; Zhang T; Xiu MH; Tang W; Han M; Yun LT; Chen DC; Chen S; Tan SP; Soares JC; Tang WJ; Zhang XY
    Schizophr Res; 2016 Oct; 176(2-3):196-200. PubMed ID: 27237600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased interleukin-10 serum levels in first-episode drug-naïve schizophrenia: relationship to psychopathology.
    Xiu MH; Yang GG; Tan YL; Chen DC; Tan SP; Wang ZR; Yang FD; Okusaga O; Soares JC; Zhang XY
    Schizophr Res; 2014 Jun; 156(1):9-14. PubMed ID: 24766914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased IL-3 serum levels in chronic patients with schizophrenia: Associated with psychopathology.
    Xiu MH; Lin CG; Tian L; Tan YL; Chen J; Chen S; Tan SP; Wang ZR; Yang FD; Chen DC; Zhang XY
    Psychiatry Res; 2015 Sep; 229(1-2):225-9. PubMed ID: 26208986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
    Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment-resistant schizophrenia.
    Tan Y; Li Y; Tan S; Wang Z; Yang FD; Cao B; Zunta-Soares GB; Soares JC; Zhang XY
    Schizophr Res; 2015 Dec; 169(1-3):16-21. PubMed ID: 26549630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia.
    Borovcanin M; Jovanovic I; Dejanovic SD; Radosavljevic G; Arsenijevic N; Lukic ML
    Psychoneuroendocrinology; 2015 Jun; 56():143-7. PubMed ID: 25827958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients.
    Zhang XY; Chen DC; Xiu MH; Wang F; Qi LY; Sun HQ; Chen S; He SC; Wu GY; Haile CN; Kosten TA; Lu L; Kosten TR
    Schizophr Res; 2009 Sep; 113(2-3):151-7. PubMed ID: 19540723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum S100B in never-medicated and medicated schizophrenic patients.
    Zhang XY; Xiu MH; Song C; Chen DC; Wu GY; Haile CN; Kosten TA; Kosten TR
    J Psychiatr Res; 2010 Dec; 44(16):1236-40. PubMed ID: 20510426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
    Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of serum levels of TNF-α, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers.
    Fan N; Luo Y; Xu K; Zhang M; Ke X; Huang X; Ding Y; Wang D; Ning Y; Deng X; He H
    Schizophr Res; 2015 Dec; 169(1-3):10-15. PubMed ID: 26589393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics.
    Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
    Neuropsychopharmacology; 2005 Aug; 30(8):1532-8. PubMed ID: 15886721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced serum TNF alpha level in chronic schizophrenia patients with or without tardive dyskinesia.
    Tian L; Tan Y; Chen D; Lv M; Tan S; Soares JC; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():259-64. PubMed ID: 24995685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology.
    Zhang XY; Zhou DF; Zhang PY; Wu GY; Cao LY; Shen YC
    Schizophr Res; 2002 Oct; 57(2-3):247-58. PubMed ID: 12223256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IL-18 level, clinical symptoms and IL-18-607A/C polymorphism among chronic patients with schizophrenia in a Chinese Han population.
    Zhang XY; Tan YL; Chen DC; Tan SP; Malouta MZ; Bernard JD; Combs JL; Bhatti S; Davis MC; Kosten TR; Soares JC
    Psychoneuroendocrinology; 2016 Jun; 68():140-7. PubMed ID: 26974498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines.
    Pae CU; Yoon CH; Kim TS; Kim JJ; Park SH; Lee CU; Lee SJ; Lee C; Paik IH
    Int Immunopharmacol; 2006 Apr; 6(4):666-71. PubMed ID: 16504930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia].
    Lü LX; Guo SQ; Chen W; Li Q; Cheng J; Guo JH
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1251-4. PubMed ID: 15567770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.
    Qi LY; Xiu MH; Chen DC; Wang F; Kosten TA; Kosten TR; Zhang XY
    Neurosci Lett; 2009 Sep; 462(2):113-7. PubMed ID: 19539717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition.
    Lv MH; Tan YL; Yan SX; Tian L; Chen DC; Tan SP; Wang ZR; Yang FD; Yoon JH; Zunta-Soares GB; Soares JC; Zhang XY
    Psychopharmacology (Berl); 2015 Jan; 232(1):165-72. PubMed ID: 24958229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration.
    Akiyama K
    Schizophr Res; 1999 May; 37(1):97-106. PubMed ID: 10227112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.